NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
May 17, 2005 • Volume 2 / Number 20 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.


CCR Grand Rounds
May 24: Dr. Sam T. Hwang, Senior Investigator, Dermatology Branch, CCR, NCI. "Chemokine Receptors in Organ-Selective Cancer Metastasis"

May 31: Dr. Peter H. Duesberg, Professor of Molecular and Cell Biology, University of California, Berkeley. "Aneuploidy and Cancer: From Correlation to Causation"

CCR Grand Rounds are held 8:30 to 9:30 a.m. at the NIH campus in Bethesda, Md., in the Clinical Center's Lipsett Amphitheater.

Quitline Offers Call-Back Services
NCI's Cancer Information Service (CIS) has expanded its efforts to help smokers quit. CIS smoking cessation counselors are being trained to provide proactive, evidence-based support. CIS has provided cessation services since the early 1980s, but only recently began training staff to provide callers who have set a quit date with up to four follow-up sessions, thereby encouraging them not to relapse. It is well documented that brief clinical interventions by health care providers can increase the chances of successful cessation, as can counseling and behavioral modification therapies. Treatments with more person-to-person contact and more time with counselors are more effective than one counseling session conducted during the initial call. For help with quitting smoking, call NCI's smoking quitline at 1-877-44U-QUIT or visit NCI's smoking cessation Web site at

Dr. Mark Clanton Clanton Wins HHS Award
Dr. Mark Clanton, NCI deputy director for cancer care delivery systems, has been awarded the HHS Secretary's Distinguished Service Award. The award recognizes service that significantly advances the department's mission and goals and reinforces the importance of achievement through teams. Dr. Clanton was recognized for his participation on the Healthcare Quality Implementation team, chaired by Dr. Scott Young of the Agency for Healthcare Research and Quality. The team reported to the Medicare Governance Council and was charged with developing implementation plans for the sections of the Medicare Modernization Act (MMA) that address quality of care and quality-of-care demonstration projects within Medicare. Dr. Clanton led the subcommittee responsible for section 1016, which pertained to the Cancer Center Loan provision of the MMA. The award will be presented on May 25.

Workshop on Palliative Care Set for June
On June 13-15, ASCO and the EPEC™ Project will sponsor a train-the-trainer workshop, "Education in Palliative and End-of-Life Care for Oncology (EPEC-O)," at the Hyatt Regency Reston in Reston, Va. The workshop curriculum was developed with major funding from NCI and supplemental support from the Lance Armstrong Foundation. It is designed to give cancer care professionals the information and skills to train others about best practices in supportive oncology and end-of-life care. Attendance is limited to 100 people; the registration deadline is May 26. For more information and to register, go to

Search the NCI Cancer Bulletin
In response to reader requests, NCI has developed a method for searching the 2005 NCI Cancer Bulletin database of articles and other features. The search function can be accessed by clicking on the "Bulletin Archive/Search" link at the top right of the HTML version of the Bulletin. The destination page offers the search capability as well as links to each weekly issue. All issues from 2004 will be searchable within the next 2 weeks.

Roberts Elected to AAAS
Dr. Anita Roberts, principal investigator in the Laboratory of Cell Regulation and Carcinogenesis in NCI's CCR, was elected to membership as a Fellow in the American Academy of Arts and Sciences on April 22. Fellows are recognized for their contributions to the sciences, scholarship, public affairs, business, and the arts. Founded in 1780, the Academy addresses issues of intellectual consequence to the nation through interdisciplinary and collaborative projects and publications.

Carrington Delivers Ceppellini Lecture
Dr. Mary N. Carrington, a principal investigator in NCI's CCR, delivered the 2005 Ceppellini Lecture in Istanbul, Turkey, last month at the annual meeting of the European Federation of Immunogenetics. Dr. Carrington was honored for her substantial contribution to the field of immunogenetics. The lecture is named in honor of Ruggero Ceppellini, an Italian geneticist who was influential in the field of human leukocyte antigens (HLA). Dr. Carrington is head of the HLA Typing Section in the Laboratory of Genomic Diversity. She received her Ph.D. from Iowa State University; before joining NCI, she was a faculty member in the Immunology Department at Duke University.